Search research articles
Contact Us
Filters
Showing results (101-110 of 146) with videos related to
Page
of 15
Sort By:
The Lancet. HIV
|
August 9, 2020
Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial
Pauline D J Bollen, Cecilia L Moore, Hilda A Mujuru, et al.
The Lancet. HIV
|
February 21, 2022
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
Hylke Waalewijn, Man K Chan, Pauline D J Bollen, et al.
BMC Medical Research Methodology
|
February 21, 2022
Borrowing information across patient subgroups in clinical trials, with application to a paediatric trial
Rebecca M Turner, Anna Turkova, Cecilia L Moore, et al.
Plos One
|
October 14, 2022
Machine learning outperformed logistic regression classification even with limit sample size: A model to predict pediatric HIV mortality and clinical progression to AIDS
Sara Domínguez-Rodríguez, Miquel Serna-Pascual, Andrea Oletto, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 14, 2018
Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected Children
Alfredo Tagarro, Man Chan, Paola Zangari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 4, 2017
Cytomegalovirus DNA Detection by Polymerase Chain Reaction in Cerebrospinal Fluid of Infants With Congenital Infection: Associations With Clinical Evaluation at Birth and Implications for Follow-up
Walter-Alfredo Goycochea-Valdivia, Fernando Baquero-Artigao, Teresa Del Rosal, et al.
Trials
|
April 30, 2025
Statistical analysis plan for the "empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia" clinical trial
Sara Domínguez-Rodríguez, David Lora, Alfredo Tagarro, et al.
The Pediatric Infectious Disease Journal
|
February 12, 2026
Safety and Pharmacokinetics of the RSV Fusion Inhibitor Sisunatovir Across Two Early-phase Studies in Infants and Children With RSV Lower Respiratory Tract Infection
Sima S Toussi, Cristina Calvo, Brett Haumann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 26, 2023
Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial
Tom G Jacobs, Vivian Mumbiro, Uneisse Cassia, et al.
The Pediatric Infectious Disease Journal
|
August 11, 2020
Prevalence and Clinical Manifestations of Congenital Cytomegalovirus Infection in a Screening Program in Madrid (PICCSA Study)
Daniel Blázquez-Gamero, María Soriano-Ramos, Marta Vicente, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 146) with videos related to
Sort By:
Page
of 15
The Lancet. HIV
|
August 9, 2020
Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial
Pauline D J Bollen, Cecilia L Moore, Hilda A Mujuru, et al.
The Lancet. HIV
|
February 21, 2022
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
Hylke Waalewijn, Man K Chan, Pauline D J Bollen, et al.
BMC Medical Research Methodology
|
February 21, 2022
Borrowing information across patient subgroups in clinical trials, with application to a paediatric trial
Rebecca M Turner, Anna Turkova, Cecilia L Moore, et al.
Plos One
|
October 14, 2022
Machine learning outperformed logistic regression classification even with limit sample size: A model to predict pediatric HIV mortality and clinical progression to AIDS
Sara Domínguez-Rodríguez, Miquel Serna-Pascual, Andrea Oletto, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 14, 2018
Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected Children
Alfredo Tagarro, Man Chan, Paola Zangari, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 4, 2017
Cytomegalovirus DNA Detection by Polymerase Chain Reaction in Cerebrospinal Fluid of Infants With Congenital Infection: Associations With Clinical Evaluation at Birth and Implications for Follow-up
Walter-Alfredo Goycochea-Valdivia, Fernando Baquero-Artigao, Teresa Del Rosal, et al.
Trials
|
April 30, 2025
Statistical analysis plan for the "empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia" clinical trial
Sara Domínguez-Rodríguez, David Lora, Alfredo Tagarro, et al.
The Pediatric Infectious Disease Journal
|
February 12, 2026
Safety and Pharmacokinetics of the RSV Fusion Inhibitor Sisunatovir Across Two Early-phase Studies in Infants and Children With RSV Lower Respiratory Tract Infection
Sima S Toussi, Cristina Calvo, Brett Haumann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 26, 2023
Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial
Tom G Jacobs, Vivian Mumbiro, Uneisse Cassia, et al.
The Pediatric Infectious Disease Journal
|
August 11, 2020
Prevalence and Clinical Manifestations of Congenital Cytomegalovirus Infection in a Screening Program in Madrid (PICCSA Study)
Daniel Blázquez-Gamero, María Soriano-Ramos, Marta Vicente, et al.
Page
of 15